nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.0554	0.07	CbGbCtD
Tranylcypromine—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0364	0.046	CbGbCtD
Tranylcypromine—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0251	0.0317	CbGbCtD
Tranylcypromine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0244	0.0308	CbGbCtD
Tranylcypromine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0229	0.029	CbGbCtD
Tranylcypromine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0225	0.0284	CbGbCtD
Tranylcypromine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0212	0.0267	CbGbCtD
Tranylcypromine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0212	0.0267	CbGbCtD
Tranylcypromine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0207	0.0262	CbGbCtD
Tranylcypromine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0207	0.0262	CbGbCtD
Tranylcypromine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0203	0.0256	CbGbCtD
Tranylcypromine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0191	0.0242	CbGbCtD
Tranylcypromine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0191	0.0241	CbGbCtD
Tranylcypromine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0191	0.0241	CbGbCtD
Tranylcypromine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0185	0.0234	CbGbCtD
Tranylcypromine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0179	0.0226	CbGbCtD
Tranylcypromine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0174	0.022	CbGbCtD
Tranylcypromine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0174	0.022	CbGbCtD
Tranylcypromine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0174	0.0219	CbGbCtD
Tranylcypromine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0172	0.0218	CbGbCtD
Tranylcypromine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0172	0.0218	CbGbCtD
Tranylcypromine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.016	0.0202	CbGbCtD
Tranylcypromine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0158	0.0199	CbGbCtD
Tranylcypromine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0158	0.0199	CbGbCtD
Tranylcypromine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0157	0.0198	CbGbCtD
Tranylcypromine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0157	0.0198	CbGbCtD
Tranylcypromine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0151	0.019	CbGbCtD
Tranylcypromine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0149	0.0188	CbGbCtD
Tranylcypromine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0145	0.0183	CbGbCtD
Tranylcypromine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0144	0.0182	CbGbCtD
Tranylcypromine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0136	0.0172	CbGbCtD
Tranylcypromine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0132	0.0167	CbGbCtD
Tranylcypromine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0131	0.0165	CbGbCtD
Tranylcypromine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0131	0.0165	CbGbCtD
Tranylcypromine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0125	0.0158	CbGbCtD
Tranylcypromine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0119	0.0151	CbGbCtD
Tranylcypromine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0119	0.0151	CbGbCtD
Tranylcypromine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0118	0.0149	CbGbCtD
Tranylcypromine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0111	0.014	CbGbCtD
Tranylcypromine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0111	0.014	CbGbCtD
Tranylcypromine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.01	0.0127	CbGbCtD
Tranylcypromine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.01	0.0127	CbGbCtD
Tranylcypromine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00865	0.0109	CbGbCtD
Tranylcypromine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0084	0.0106	CbGbCtD
Tranylcypromine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0076	0.00959	CbGbCtD
Tranylcypromine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0076	0.00959	CbGbCtD
Tranylcypromine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00728	0.0092	CbGbCtD
Tranylcypromine—Amphetamine—CARTPT—acquired immunodeficiency syndrome	0.0036	1	CrCbGaD
Tranylcypromine—MAOB—nerve—acquired immunodeficiency syndrome	0.00232	0.0646	CbGeAlD
Tranylcypromine—MAOA—nerve—acquired immunodeficiency syndrome	0.00198	0.0551	CbGeAlD
Tranylcypromine—MAOB—blood plasma—acquired immunodeficiency syndrome	0.00175	0.0489	CbGeAlD
Tranylcypromine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00153	0.0426	CbGeAlD
Tranylcypromine—MAOA—blood plasma—acquired immunodeficiency syndrome	0.00149	0.0417	CbGeAlD
Tranylcypromine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00125	0.0348	CbGeAlD
Tranylcypromine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00118	0.033	CbGeAlD
Tranylcypromine—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.00112	0.0313	CbGeAlD
Tranylcypromine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000902	0.0252	CbGeAlD
Tranylcypromine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000888	0.0248	CbGeAlD
Tranylcypromine—MAOA—retina—acquired immunodeficiency syndrome	0.000818	0.0228	CbGeAlD
Tranylcypromine—CYP2A6—vagina—acquired immunodeficiency syndrome	0.000806	0.0225	CbGeAlD
Tranylcypromine—CYP2A6—lung—acquired immunodeficiency syndrome	0.000762	0.0213	CbGeAlD
Tranylcypromine—MAOB—digestive system—acquired immunodeficiency syndrome	0.000673	0.0188	CbGeAlD
Tranylcypromine—MAOB—blood—acquired immunodeficiency syndrome	0.000641	0.0179	CbGeAlD
Tranylcypromine—MAOB—spinal cord—acquired immunodeficiency syndrome	0.000618	0.0173	CbGeAlD
Tranylcypromine—MAOB—vagina—acquired immunodeficiency syndrome	0.000595	0.0166	CbGeAlD
Tranylcypromine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000587	0.0164	CbGeAlD
Tranylcypromine—MAOA—digestive system—acquired immunodeficiency syndrome	0.000574	0.016	CbGeAlD
Tranylcypromine—MAOB—lung—acquired immunodeficiency syndrome	0.000562	0.0157	CbGeAlD
Tranylcypromine—CYP2C19—blood—acquired immunodeficiency syndrome	0.000559	0.0156	CbGeAlD
Tranylcypromine—MAOA—blood—acquired immunodeficiency syndrome	0.000547	0.0153	CbGeAlD
Tranylcypromine—CYP2A6—brain—acquired immunodeficiency syndrome	0.000539	0.0151	CbGeAlD
Tranylcypromine—MAOA—spinal cord—acquired immunodeficiency syndrome	0.000527	0.0147	CbGeAlD
Tranylcypromine—MAOB—nervous system—acquired immunodeficiency syndrome	0.000521	0.0145	CbGeAlD
Tranylcypromine—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000518	0.0145	CbGeAlD
Tranylcypromine—MAOA—vagina—acquired immunodeficiency syndrome	0.000507	0.0142	CbGeAlD
Tranylcypromine—MAOB—central nervous system—acquired immunodeficiency syndrome	0.000501	0.014	CbGeAlD
Tranylcypromine—MAOA—lung—acquired immunodeficiency syndrome	0.00048	0.0134	CbGeAlD
Tranylcypromine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000479	0.0134	CbGeAlD
Tranylcypromine—CYP1A2—blood—acquired immunodeficiency syndrome	0.000457	0.0127	CbGeAlD
Tranylcypromine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000455	0.0127	CbGeAlD
Tranylcypromine—MAOA—nervous system—acquired immunodeficiency syndrome	0.000444	0.0124	CbGeAlD
Tranylcypromine—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000436	0.0122	CbGeAlD
Tranylcypromine—CYP2C9—blood—acquired immunodeficiency syndrome	0.000433	0.0121	CbGeAlD
Tranylcypromine—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000431	0.012	CbGeAlD
Tranylcypromine—MAOA—central nervous system—acquired immunodeficiency syndrome	0.000428	0.0119	CbGeAlD
Tranylcypromine—CYP2E1—blood—acquired immunodeficiency syndrome	0.000411	0.0115	CbGeAlD
Tranylcypromine—CYP1A2—lung—acquired immunodeficiency syndrome	0.0004	0.0112	CbGeAlD
Tranylcypromine—MAOB—brain—acquired immunodeficiency syndrome	0.000398	0.0111	CbGeAlD
Tranylcypromine—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000396	0.011	CbGeAlD
Tranylcypromine—MAOB—lymph node—acquired immunodeficiency syndrome	0.000385	0.0107	CbGeAlD
Tranylcypromine—CYP2E1—lung—acquired immunodeficiency syndrome	0.00036	0.0101	CbGeAlD
Tranylcypromine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000347	0.00969	CbGeAlD
Tranylcypromine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000341	0.00953	CbGeAlD
Tranylcypromine—MAOA—brain—acquired immunodeficiency syndrome	0.00034	0.00948	CbGeAlD
Tranylcypromine—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000333	0.00931	CbGeAlD
Tranylcypromine—CYP3A4—blood—acquired immunodeficiency syndrome	0.00033	0.00923	CbGeAlD
Tranylcypromine—MAOA—lymph node—acquired immunodeficiency syndrome	0.000328	0.00916	CbGeAlD
Tranylcypromine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000325	0.00908	CbGeAlD
Tranylcypromine—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000321	0.00896	CbGeAlD
Tranylcypromine—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000304	0.00181	CcSEcCtD
Tranylcypromine—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000304	0.00181	CcSEcCtD
Tranylcypromine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000303	0.0018	CcSEcCtD
Tranylcypromine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000303	0.0018	CcSEcCtD
Tranylcypromine—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000303	0.0018	CcSEcCtD
Tranylcypromine—Chills—Lamivudine—acquired immunodeficiency syndrome	0.000302	0.00179	CcSEcCtD
Tranylcypromine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000301	0.00179	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000301	0.00179	CcSEcCtD
Tranylcypromine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.0003	0.00178	CcSEcCtD
Tranylcypromine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.0003	0.00178	CcSEcCtD
Tranylcypromine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.0003	0.00178	CcSEcCtD
Tranylcypromine—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.0003	0.00178	CcSEcCtD
Tranylcypromine—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.0003	0.00178	CcSEcCtD
Tranylcypromine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000299	0.00177	CcSEcCtD
Tranylcypromine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000298	0.00177	CcSEcCtD
Tranylcypromine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000298	0.00177	CcSEcCtD
Tranylcypromine—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000297	0.00176	CcSEcCtD
Tranylcypromine—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000297	0.00176	CcSEcCtD
Tranylcypromine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000296	0.00176	CcSEcCtD
Tranylcypromine—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000295	0.00175	CcSEcCtD
Tranylcypromine—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000295	0.00175	CcSEcCtD
Tranylcypromine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000293	0.00174	CcSEcCtD
Tranylcypromine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.00174	CcSEcCtD
Tranylcypromine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000291	0.00173	CcSEcCtD
Tranylcypromine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000289	0.00172	CcSEcCtD
Tranylcypromine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000289	0.00172	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000288	0.00171	CcSEcCtD
Tranylcypromine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000287	0.00171	CcSEcCtD
Tranylcypromine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000287	0.0017	CcSEcCtD
Tranylcypromine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000287	0.0017	CcSEcCtD
Tranylcypromine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000286	0.0017	CcSEcCtD
Tranylcypromine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000286	0.0017	CcSEcCtD
Tranylcypromine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000286	0.0017	CcSEcCtD
Tranylcypromine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000286	0.0017	CcSEcCtD
Tranylcypromine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000285	0.00169	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000284	0.00169	CcSEcCtD
Tranylcypromine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000284	0.00168	CcSEcCtD
Tranylcypromine—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000284	0.00168	CcSEcCtD
Tranylcypromine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000282	0.00167	CcSEcCtD
Tranylcypromine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000282	0.00167	CcSEcCtD
Tranylcypromine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000282	0.00167	CcSEcCtD
Tranylcypromine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000281	0.00167	CcSEcCtD
Tranylcypromine—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000281	0.00167	CcSEcCtD
Tranylcypromine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000281	0.00167	CcSEcCtD
Tranylcypromine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.00028	0.00166	CcSEcCtD
Tranylcypromine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.00028	0.00166	CcSEcCtD
Tranylcypromine—Rash—Didanosine—acquired immunodeficiency syndrome	0.00028	0.00166	CcSEcCtD
Tranylcypromine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000279	0.00166	CcSEcCtD
Tranylcypromine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000279	0.00166	CcSEcCtD
Tranylcypromine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000278	0.00165	CcSEcCtD
Tranylcypromine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000277	0.00164	CcSEcCtD
Tranylcypromine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000277	0.00164	CcSEcCtD
Tranylcypromine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000277	0.00164	CcSEcCtD
Tranylcypromine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000276	0.00164	CcSEcCtD
Tranylcypromine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000276	0.00164	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000275	0.00164	CcSEcCtD
Tranylcypromine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000275	0.00163	CcSEcCtD
Tranylcypromine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000275	0.00163	CcSEcCtD
Tranylcypromine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000275	0.00163	CcSEcCtD
Tranylcypromine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000275	0.00163	CcSEcCtD
Tranylcypromine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000274	0.00163	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000274	0.00162	CcSEcCtD
Tranylcypromine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000273	0.00162	CcSEcCtD
Tranylcypromine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000272	0.00162	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000272	0.00161	CcSEcCtD
Tranylcypromine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000271	0.00161	CcSEcCtD
Tranylcypromine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000271	0.00161	CcSEcCtD
Tranylcypromine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00161	CcSEcCtD
Tranylcypromine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.0016	CcSEcCtD
Tranylcypromine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000268	0.00749	CbGeAlD
Tranylcypromine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000268	0.00159	CcSEcCtD
Tranylcypromine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000266	0.00158	CcSEcCtD
Tranylcypromine—Pain—Indinavir—acquired immunodeficiency syndrome	0.000266	0.00158	CcSEcCtD
Tranylcypromine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000266	0.00158	CcSEcCtD
Tranylcypromine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000266	0.00158	CcSEcCtD
Tranylcypromine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000265	0.00158	CcSEcCtD
Tranylcypromine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000265	0.00157	CcSEcCtD
Tranylcypromine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000265	0.00157	CcSEcCtD
Tranylcypromine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000265	0.00157	CcSEcCtD
Tranylcypromine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000264	0.00157	CcSEcCtD
Tranylcypromine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000264	0.00157	CcSEcCtD
Tranylcypromine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000264	0.00737	CbGeAlD
Tranylcypromine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000263	0.00156	CcSEcCtD
Tranylcypromine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000263	0.00156	CcSEcCtD
Tranylcypromine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000263	0.00156	CcSEcCtD
Tranylcypromine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000262	0.00156	CcSEcCtD
Tranylcypromine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000262	0.00156	CcSEcCtD
Tranylcypromine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000262	0.00156	CcSEcCtD
Tranylcypromine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000261	0.00155	CcSEcCtD
Tranylcypromine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.00155	CcSEcCtD
Tranylcypromine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00026	0.00154	CcSEcCtD
Tranylcypromine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00026	0.00154	CcSEcCtD
Tranylcypromine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000258	0.00721	CbGeAlD
Tranylcypromine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000257	0.00153	CcSEcCtD
Tranylcypromine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000256	0.00152	CcSEcCtD
Tranylcypromine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000256	0.00152	CcSEcCtD
Tranylcypromine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000256	0.00152	CcSEcCtD
Tranylcypromine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000255	0.00152	CcSEcCtD
Tranylcypromine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000255	0.00152	CcSEcCtD
Tranylcypromine—CYP2E1—brain—acquired immunodeficiency syndrome	0.000255	0.00712	CbGeAlD
Tranylcypromine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000255	0.00151	CcSEcCtD
Tranylcypromine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000255	0.00151	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000254	0.00151	CcSEcCtD
Tranylcypromine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000254	0.00151	CcSEcCtD
Tranylcypromine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000254	0.0071	CbGeAlD
Tranylcypromine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000254	0.00151	CcSEcCtD
Tranylcypromine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000254	0.00151	CcSEcCtD
Tranylcypromine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000253	0.0015	CcSEcCtD
Tranylcypromine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000252	0.0015	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.00149	CcSEcCtD
Tranylcypromine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000251	0.00149	CcSEcCtD
Tranylcypromine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000251	0.00149	CcSEcCtD
Tranylcypromine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000251	0.00149	CcSEcCtD
Tranylcypromine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000251	0.00149	CcSEcCtD
Tranylcypromine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000251	0.00149	CcSEcCtD
Tranylcypromine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00025	0.00149	CcSEcCtD
Tranylcypromine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00025	0.00148	CcSEcCtD
Tranylcypromine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00025	0.00148	CcSEcCtD
Tranylcypromine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.00147	CcSEcCtD
Tranylcypromine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000248	0.00147	CcSEcCtD
Tranylcypromine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000247	0.00147	CcSEcCtD
Tranylcypromine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000246	0.00146	CcSEcCtD
Tranylcypromine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000246	0.00146	CcSEcCtD
Tranylcypromine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000246	0.00146	CcSEcCtD
Tranylcypromine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000246	0.00146	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000245	0.00146	CcSEcCtD
Tranylcypromine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000245	0.00145	CcSEcCtD
Tranylcypromine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000245	0.00145	CcSEcCtD
Tranylcypromine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000244	0.00145	CcSEcCtD
Tranylcypromine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000244	0.00145	CcSEcCtD
Tranylcypromine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000243	0.00144	CcSEcCtD
Tranylcypromine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.00144	CcSEcCtD
Tranylcypromine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000243	0.00144	CcSEcCtD
Tranylcypromine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000243	0.00144	CcSEcCtD
Tranylcypromine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000242	0.00144	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000242	0.00144	CcSEcCtD
Tranylcypromine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000242	0.00144	CcSEcCtD
Tranylcypromine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000241	0.00143	CcSEcCtD
Tranylcypromine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000241	0.00143	CcSEcCtD
Tranylcypromine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000241	0.00143	CcSEcCtD
Tranylcypromine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000241	0.00143	CcSEcCtD
Tranylcypromine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000241	0.00143	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00024	0.00143	CcSEcCtD
Tranylcypromine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00024	0.00143	CcSEcCtD
Tranylcypromine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000239	0.00142	CcSEcCtD
Tranylcypromine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000239	0.00142	CcSEcCtD
Tranylcypromine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000239	0.00142	CcSEcCtD
Tranylcypromine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000239	0.00142	CcSEcCtD
Tranylcypromine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000238	0.00141	CcSEcCtD
Tranylcypromine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000237	0.00141	CcSEcCtD
Tranylcypromine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000235	0.0014	CcSEcCtD
Tranylcypromine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000235	0.0014	CcSEcCtD
Tranylcypromine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000234	0.00139	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000234	0.00139	CcSEcCtD
Tranylcypromine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.00139	CcSEcCtD
Tranylcypromine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000234	0.00139	CcSEcCtD
Tranylcypromine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.00138	CcSEcCtD
Tranylcypromine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.00138	CcSEcCtD
Tranylcypromine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.00138	CcSEcCtD
Tranylcypromine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000231	0.00137	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.00137	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00023	0.00137	CcSEcCtD
Tranylcypromine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000229	0.00136	CcSEcCtD
Tranylcypromine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000229	0.00136	CcSEcCtD
Tranylcypromine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000229	0.00136	CcSEcCtD
Tranylcypromine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000228	0.00135	CcSEcCtD
Tranylcypromine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000226	0.00134	CcSEcCtD
Tranylcypromine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.00134	CcSEcCtD
Tranylcypromine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000225	0.00134	CcSEcCtD
Tranylcypromine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.00133	CcSEcCtD
Tranylcypromine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000224	0.00133	CcSEcCtD
Tranylcypromine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000223	0.00133	CcSEcCtD
Tranylcypromine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.00133	CcSEcCtD
Tranylcypromine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000223	0.00132	CcSEcCtD
Tranylcypromine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.00132	CcSEcCtD
Tranylcypromine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.00132	CcSEcCtD
Tranylcypromine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.00132	CcSEcCtD
Tranylcypromine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.00132	CcSEcCtD
Tranylcypromine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000221	0.00131	CcSEcCtD
Tranylcypromine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.00129	CcSEcCtD
Tranylcypromine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000216	0.00128	CcSEcCtD
Tranylcypromine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.00127	CcSEcCtD
Tranylcypromine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.00127	CcSEcCtD
Tranylcypromine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000214	0.00127	CcSEcCtD
Tranylcypromine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000214	0.00127	CcSEcCtD
Tranylcypromine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000213	0.00126	CcSEcCtD
Tranylcypromine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000213	0.00126	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.00126	CcSEcCtD
Tranylcypromine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.00126	CcSEcCtD
Tranylcypromine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000211	0.00125	CcSEcCtD
Tranylcypromine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000211	0.00125	CcSEcCtD
Tranylcypromine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000211	0.00125	CcSEcCtD
Tranylcypromine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00021	0.00124	CcSEcCtD
Tranylcypromine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.00123	CcSEcCtD
Tranylcypromine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.00123	CcSEcCtD
Tranylcypromine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.00122	CcSEcCtD
Tranylcypromine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000206	0.00122	CcSEcCtD
Tranylcypromine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.00122	CcSEcCtD
Tranylcypromine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.00122	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.00122	CcSEcCtD
Tranylcypromine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.00121	CcSEcCtD
Tranylcypromine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.00121	CcSEcCtD
Tranylcypromine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.0012	CcSEcCtD
Tranylcypromine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000202	0.00563	CbGeAlD
Tranylcypromine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000201	0.00119	CcSEcCtD
Tranylcypromine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.00118	CcSEcCtD
Tranylcypromine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000199	0.00118	CcSEcCtD
Tranylcypromine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.00118	CcSEcCtD
Tranylcypromine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.00118	CcSEcCtD
Tranylcypromine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000198	0.00117	CcSEcCtD
Tranylcypromine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.00117	CcSEcCtD
Tranylcypromine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000196	0.00116	CcSEcCtD
Tranylcypromine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000196	0.00116	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.00116	CcSEcCtD
Tranylcypromine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000195	0.00116	CcSEcCtD
Tranylcypromine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000194	0.00115	CcSEcCtD
Tranylcypromine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.00114	CcSEcCtD
Tranylcypromine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.00113	CcSEcCtD
Tranylcypromine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.00112	CcSEcCtD
Tranylcypromine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.00112	CcSEcCtD
Tranylcypromine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000187	0.00111	CcSEcCtD
Tranylcypromine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.00111	CcSEcCtD
Tranylcypromine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.0011	CcSEcCtD
Tranylcypromine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000185	0.0011	CcSEcCtD
Tranylcypromine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000185	0.0011	CcSEcCtD
Tranylcypromine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000185	0.0011	CcSEcCtD
Tranylcypromine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.00109	CcSEcCtD
Tranylcypromine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.00107	CcSEcCtD
Tranylcypromine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.00106	CcSEcCtD
Tranylcypromine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.00106	CcSEcCtD
Tranylcypromine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.00105	CcSEcCtD
Tranylcypromine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.00105	CcSEcCtD
Tranylcypromine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.00105	CcSEcCtD
Tranylcypromine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000175	0.00104	CcSEcCtD
Tranylcypromine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.00102	CcSEcCtD
Tranylcypromine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.00102	CcSEcCtD
Tranylcypromine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.00102	CcSEcCtD
Tranylcypromine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000167	0.000992	CcSEcCtD
Tranylcypromine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000983	CcSEcCtD
Tranylcypromine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.000982	CcSEcCtD
Tranylcypromine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.000974	CcSEcCtD
Tranylcypromine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.000973	CcSEcCtD
Tranylcypromine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.00097	CcSEcCtD
Tranylcypromine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000968	CcSEcCtD
Tranylcypromine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.000945	CcSEcCtD
Tranylcypromine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000938	CcSEcCtD
Tranylcypromine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.000937	CcSEcCtD
Tranylcypromine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.000936	CcSEcCtD
Tranylcypromine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000931	CcSEcCtD
Tranylcypromine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000917	CcSEcCtD
Tranylcypromine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000902	CcSEcCtD
Tranylcypromine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000894	CcSEcCtD
Tranylcypromine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000893	CcSEcCtD
Tranylcypromine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000888	CcSEcCtD
Tranylcypromine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000883	CcSEcCtD
Tranylcypromine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000842	CcSEcCtD
